Home » Topics » BioWorld Science

BioWorld Science
RSS

MPL vaccine adjuvant offered for licensing by Ribi

May 19, 1997

Krenitsky seeks partners to develop MAO-A inhibitors

May 19, 1997

Notes from Ribi's 16th Annual Meeting of Stockholders

May 19, 1997

Vical: Q1 1997 highlights

May 19, 1997

Ilex Oncology: Q1 1997 highlights

May 19, 1997

ImmuLogic: Q1 1997 highlights

May 19, 1997

Watson: Q1 1997 highlights

May 19, 1997

Salix reports promising clinical results for ulcerative colitis treatment

May 16, 1997

NIH announces prospective grant of licenses for IL-12 antibodies

May 16, 1997

NIH announces prospective grant of exclusive license for IL-13 receptor-specific chimeric antibodies

May 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...